Home

Pacific Biosciences of California, Inc. - Common Stock (PACB)

1.3500
+0.0300 (2.27%)

Pacific Biosciences is a biotechnology company that specializes in developing advanced sequencing technologies designed to enable detailed analysis of genetic material

The company's innovative platforms are used for applications such as genomics research, clinical diagnostics, and personalized medicine, providing researchers and healthcare professionals with powerful tools for understanding complex biological systems. Their technology focuses on real-time, high-fidelity sequencing, allowing for the detection of genetic variations that traditional methods may miss, thereby contributing to significant advancements in the fields of genomics and molecular biology.

SummaryNewsPress ReleasesChartHistoricalFAQ
Previous Close1.320
Open1.300
Bid1.370
Ask1.390
Day's Range1.300 - 1.450
52 Week Range1.160 - 5.230
Volume10,878,133
Market Cap333.56M
PE Ratio (TTM)-0.9247
EPS (TTM)-1.5
Dividend & YieldN/A (N/A)
1 Month Average Volume14,615,892

News & Press Releases

Where Pacific Biosciences Stands With Analystsbenzinga.com
Via Benzinga · February 18, 2025
Goodyear Tire & Rubber Posts Upbeat Results, Joins Nu Skin, Pacific Biosciences of California, Airbnb, Roku And Other Big Stocks Moving Higher On Fridaybenzinga.com
Via Benzinga · February 14, 2025
PacBio (NASDAQ:PACB) Misses Q4 Sales Targets
Genomics company Pacific Biosciences of California (NASDAQPACB) missed Wall Street’s revenue expectations in Q4 CY2024, with sales falling 32.8% year on year to $39.22 million. Its non-GAAP loss of $0.20 per share was 15.5% below analysts’ consensus estimates.
Via StockStory · February 13, 2025
Earnings Scheduled For February 13, 2025benzinga.com
Via Benzinga · February 13, 2025
PacBio (PACB) Q4 Earnings Report Preview: What To Look For
Genomics company Pacific Biosciences of California (NASDAQPACB) will be announcing earnings results tomorrow after market hours. Here’s what investors should know.
Via StockStory · February 12, 2025
What Analysts Are Saying About Pacific Biosciences Stockbenzinga.com
Via Benzinga · January 23, 2025
What 5 Analyst Ratings Have To Say About Pacific Biosciencesbenzinga.com
Via Benzinga · August 28, 2024
Analyst Scoreboard: 5 Ratings For Pacific Biosciencesbenzinga.com
Via Benzinga · August 12, 2024
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Boughtfool.com
With Ark Invest ending 2024 on a strong note, the aggressive growth icon is hoping to build on that momentum in 2025.
Via The Motley Fool · January 7, 2025
Cathie Wood's Ark Invest Bets Big On Biotech Again As Pacific Biosciences Grabs Spotlightbenzinga.com
Cathie Wood is investing in PacBio, a biotech company with potential for genomics revolution. ARK Invest is confident in its long-term growth.
Via Benzinga · December 5, 2024
10 Health Care Stocks Whale Activity In Today's Sessionbenzinga.com
Via Benzinga · December 4, 2024
Deciphering Disruption: Inside Cathie Wood's Latest Plays
Cathie Wood's recent stock market activity offers a glimpse into her evolving investment strategy and the potential of disruptive technologies.
Via MarketBeat · November 16, 2024
Peering Into Pacific Biosciences's Recent Short Interestbenzinga.com
Via Benzinga · August 8, 2024
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Boughtfool.com
The rock star money manager is starting to roll with the rallying market.
Via The Motley Fool · November 12, 2024
Sweetgreen Posts Downbeat Results, Joins Evolent Health, Redfin, Pinterest And Other Big Stocks Moving Lower In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · November 8, 2024
Baidu, XPeng And Other Big Stocks Moving Lower In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · October 14, 2024
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 47%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · October 14, 2024
S&P 500 Moves Higher; BlackRock Reports Upbeat Resultsbenzinga.com
Via Benzinga · October 11, 2024
Gold Gains 1%; Wells Fargo Shares Gain After Q3 Earningsbenzinga.com
Via Benzinga · October 11, 2024
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga.com
Via Benzinga · October 11, 2024
Fastenal Posts Upbeat Earnings, Joins Wells Fargo, JPMorgan And Other Big Stocks Moving Higher On Fridaybenzinga.com
Via Benzinga · October 11, 2024
A Biotech Breakout Will Be Led By Small Capstalkmarkets.com
It’s hard to focus on biotech stocks right now because there are many distractions. The Fed and the rate cuts, AI and semiconductor stocks and geopolitical turmoil seemingly worse than ever.
Via Talk Markets · September 23, 2024
Quanex Building Products Posts Better-Than-Expected Results, Joins Zumiez, Guidewire Software, Smartsheet And Other Big Stocks Moving Higher On Fridaybenzinga.com
Via Benzinga · September 6, 2024
Applied Materials, Amcor, RLX Technology And Other Big Stocks Moving Lower In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · August 16, 2024
PACB Stock Earnings: Pacific Biosciences Beats EPS, Misses Revenue for Q2 2024investorplace.com
PACB stock results show that Pacific Biosciences beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 7, 2024